|
| 37698384 | Pharmacological characterization of SAGE-718, a novel positive allosteric modulator of N-methyl-d-aspartate receptors. | Br J Pharmacol | 2024 |
| 36645496 | Novel neuroactive steroids as positive allosteric modulators of NMDA receptors: mechanism, site of action, and rescue pharmacology on GRIN variants associated with neurological conditions. | Cell Mol Life Sci | 2023 |
| 37491938 | Zuranolone for the Treatment of Postpartum Depression. | Am J Psychiatry | 2023 |
| 37132201 | Zuranolone for the Treatment of Adults With Major Depressive Disorder: A Randomized, Placebo-Controlled Phase 3 Trial. | Am J Psychiatry | 2023 |
| 34352138 | A phase 1 double-blind, placebo-controlled study of zuranolone (SAGE-217) in a phase advance model of insomnia in healthy adults. | Hum Psychopharmacol | 2022 |
| 35378149 | Patient-reported health-related quality of life from a randomized, placebo-controlled phase 2 trial of zuranolone in adults with major depressive disorder. | J Affect Disord | 2022 |
| 35431797 | Preventing Phosphorylation of the GABA <sub><i>A</i></sub> R β3 Subunit Compromises the Behavioral Effects of Neuroactive Steroids. | Front Mol Neurosci | 2022 |
| 35785990 | SAGE-718: A First-in-Class <i>N</i>-Methyl-d-Aspartate Receptor Positive Allosteric Modulator for the Potential Treatment of Cognitive Impairment. | J Med Chem | 2022 |
| 33441369 | Oxysterols Modulate the Acute Effects of Ethanol on Hippocampal <i>N</i>-Methyl-d-Aspartate Receptors, Long-Term Potentiation, and Learning. | J Pharmacol Exp Ther | 2021 |
| 34190962 | Effect of Zuranolone vs Placebo in Postpartum Depression: A Randomized Clinical Trial. | JAMA Psychiatry | 2021 |
| 33387701 | Zuranolone as an oral adjunct to treatment of Parkinsonian tremor: A phase 2, open-label study. | J Neurol Sci | 2021 |
| 31338688 | SAGE-217, A Novel GABA<sub>A</sub> Receptor Positive Allosteric Modulator: Clinical Pharmacology and Tolerability in Randomized Phase I Dose-Finding Studies. | Clin Pharmacokinet | 2020 |
| 32976892 | Preclinical characterization of zuranolone (SAGE-217), a selective neuroactive steroid GABA<sub>A</sub> receptor positive allosteric modulator. | Neuropharmacology | 2020 |
| 32830245 | Allosteric modulation of NMDA receptors prevents the antibody effects of patients with anti-NMDAR encephalitis. | Brain | 2020 |
| 32552741 | 25-Hydroxycholesterol amplifies microglial IL-1β production in an apoE isoform-dependent manner. | J Neuroinflammation | 2020 |
| 30804752 | Neuroactive Steroids Reverse Tonic Inhibitory Deficits in Fragile X Syndrome Mouse Model. | Front Mol Neurosci | 2019 |
| 31239352 | Metabotropic, but not allosteric, effects of neurosteroids on GABAergic inhibition depend on the phosphorylation of GABA<sub>A</sub> receptors. | J Biol Chem | 2019 |
| 31483961 | Trial of SAGE-217 in Patients with Major Depressive Disorder. | N Engl J Med | 2019 |
| 31255299 | Brexanolone injection for post-partum depression treatment - Authors' reply. | Lancet | 2019 |
| 31390523 | Neuroactive Steroid <i>N</i>-Methyl-d-aspartate Receptor Positive Allosteric Modulators: Synthesis, SAR, and Pharmacological Activity. | J Med Chem | 2019 |
| 29772269 | A new method for determining levels of sedation in dogs: A pilot study with propofol and a novel neuroactive steroid anesthetic. | J Neurosci Methods | 2018 |
| 29476014 | Positive Allosteric Modulation as a Potential Therapeutic Strategy in Anti-NMDA Receptor Encephalitis. | J Neurosci | 2018 |
| 27743930 | Endogenous and synthetic neuroactive steroids evoke sustained increases in the efficacy of GABAergic inhibition via a protein kinase C-dependent mechanism. | Neuropharmacology | 2017 |
| 28109985 | The synthetic neuroactive steroid SGE-516 reduces status epilepticus and neuronal cell death in a rat model of soman intoxication. | Epilepsy Behav | 2017 |
| 28370307 | Open-label, proof-of-concept study of brexanolone in the treatment of severe postpartum depression. | Hum Psychopharmacol | 2017 |
| 29127345 | The synthetic neuroactive steroid SGE-516 reduces seizure burden and improves survival in a Dravet syndrome mouse model. | Sci Rep | 2017 |
| 28753313 | Neuroactive Steroids. 2. 3α-Hydroxy-3β-methyl-21-(4-cyano-1H-pyrazol-1'-yl)-19-nor-5β-pregnan-20-one (SAGE-217): A Clinical Next Generation Neuroactive Steroid Positive Allosteric Modulator of the (γ-Aminobutyric Acid)<sub>A</sub> Receptor. | J Med Chem | 2017 |
| 28779545 | Brexanolone as adjunctive therapy in super-refractory status epilepticus. | Ann Neurol | 2017 |
| 28619476 | Brexanolone (SAGE-547 injection) in post-partum depression: a randomised controlled trial. | Lancet | 2017 |
| 28521115 | Anticonvulsant profile of the neuroactive steroid, SGE-516, in animal models. | Epilepsy Res | 2017 |
| 26922656 | AZD8529, a positive allosteric modulator at the mGluR2 receptor, does not improve symptoms in schizophrenia: A proof of principle study. | Schizophr Res | 2016 |
| 26308557 | Rescue of deficient amygdala tonic γ-aminobutyric acidergic currents in the Fmr-/y mouse model of fragile X syndrome by a novel γ-aminobutyric acid type A receptor-positive allosteric modulator. | J Neurosci Res | 2016 |
| 26873083 | Attenuation of nicotine-taking and nicotine-seeking behavior by the mGlu2 receptor positive allosteric modulators AZD8418 and AZD8529 in rats. | Psychopharmacology (Berl) | 2016 |
| 25377730 | Interaction between positive allosteric modulators and trapping blockers of the NMDA receptor channel. | Br J Pharmacol | 2015 |
| 25799373 | Neuroactive Steroids. 1. Positive Allosteric Modulators of the (γ-Aminobutyric Acid)A Receptor: Structure-Activity Relationships of Heterocyclic Substitution at C-21. | J Med Chem | 2015 |
| 25253471 | EEG-β/γ spectral power elevation in rat: a translatable biomarker elicited by GABA(Aα2/3)-positive allosteric modulators at nonsedating anxiolytic doses. | J Neurophysiol | 2015 |
| 24878244 | Different oxysterols have opposing actions at N-methyl-D-aspartate receptors. | Neuropharmacology | 2014 |
| 23410232 | AZD1080, a novel GSK3 inhibitor, rescues synaptic plasticity deficits in rodent brain and exhibits peripheral target engagement in humans. | J Neurochem | 2013 |
| 24174662 | The major brain cholesterol metabolite 24(S)-hydroxycholesterol is a potent allosteric modulator of N-methyl-D-aspartate receptors. | J Neurosci | 2013 |
| 20506301 | Absence of direct effects on the dopamine D2 receptor by mGluR2/3-selective receptor agonists LY 354,740 and LY 379,268. | Synapse | 2011 |
| 21045198 | Elucidation of a novel bioactivation pathway of a 3,4-unsubstituted isoxazole in human liver microsomes: formation of a glutathione adduct of a cyanoacrolein derivative after isoxazole ring opening. | Drug Metab Dispos | 2011 |
| 21147987 | Stimulus-specific adaptation in auditory cortex is an NMDA-independent process distinct from the sensory novelty encoded by the mismatch negativity. | J Neurosci | 2010 |
| 19615981 | Selective alpha7 nicotinic receptor activation by AZD0328 enhances cortical dopamine release and improves learning and attentional processes. | Biochem Pharmacol | 2009 |
| 19906975 | A selective allosteric potentiator of the M1 muscarinic acetylcholine receptor increases activity of medial prefrontal cortical neurons and restores impairments in reversal learning. | J Neurosci | 2009 |
| 15846002 | Fimbria-fornix lesions compromise the induction of long-term potentiation at the Schaffer collateral-CA1 synapse in the rat in vivo. | J Neurophysiol | 2005 |
| 15513941 | Metabotropic glutamate receptors modulate feedback inhibition in a developmentally regulated manner in rat dentate gyrus. | J Physiol | 2004 |
| 12550741 | Functional interactions between cannabinoid and metabotropic glutamate receptors in the central nervous system. | Curr Opin Pharmacol | 2003 |
| 12351716 | Altered histone acetylation at glutamate receptor 2 and brain-derived neurotrophic factor genes is an early event triggered by status epilepticus. | J Neurosci | 2002 |
| 12769618 | The roles of metabotropic glutamate receptors in seizures and epilepsy. | Curr Drug Targets CNS Neurol Disord | 2002 |
| 11245688 | Reduced excitatory drive onto interneurons in the dentate gyrus after status epilepticus. | J Neurosci | 2001 |